Posts by Admin BioAlps
Swiss Venture Capital Report 2020
The Swiss Venture Capital Report 2020 is out | Encouraging results for biotech and healthcare IT sectors The 8th edition of the Swiss Venture Capital Report (SVCR), published by startupticker.ch and the investor association SECA, depicts changes in the Swiss innovation landscape. After a decrease in investment in Swiss biotech startups in 2018,…
Read MoreNovostia receives grant from the European Commission
European Innovation Council (EIC) Accelerator | Novostia part of the 9 selected Swiss startups The European Commission selected 75 startups and SMEs out of 1852 applicants from the European Union to take part in the EIC Accelerator pilot. Novostia, the Neuchâtel-based medtech startup, was selected among the Swiss projects. €278 million will be allocated to…
Read MoreGeNeuro closes €17.5 million private placement
GeNeuro secures investment to further clinical trials GeNeuro, the Geneva-based biopharmaceutical company, announced on 31 January 2020 the securing of a €17.5 international private placement. This investment will support the company in competing its clinical trial of temelimab in multiple sclerosis patients, as well as advance the preclinical programme for ALS and more. Read…
Read MoreEndotelix Diagnostics wins VentureKick Stage 3
Endotelix Diagnostics Sàrl | Solution provider for Antiphospholipid Syndrome In 2020, VentureKick allocated CHF 5 million to 80 Swiss startup projects. The University of Geneva spin-off, Endotelix Diagnostics, which specialises in point-of-care diagnostics for autoimmune diseases, won the Stage 3 prize of CHF 150’000. Antiphospholipid Syndrome (APS) is one of the main causes of strokes in…
Read MoreMerck invests €250 million in Switzerland
Merck Biotech Development Center | New Facility in Switzerland On 27 January 2020, Merck announced a €250 million investment to build a new research and manufacturing facility in Corsier-sur-Vevey, in the canton of Vaud. The investment, to be made between 2019 and 2022, will help secure the needed facility to develop the biotech…
Read MoreNanolive is moving to a new office location
Another milestone for Nanolive, as the company moves to new offices In 2013, Nanolive started its adventure in a small office space. In 2020, the company will set up its new 1’100 m2 quarters in Tolochenaz. The Grand Opening will take place on Friday 14th February as of 4:30PM. You can take part…
Read MoreNTN Innovation Booster | Contribute to the Future of Healthcare with SILAB
Join SILAB and take part in Innosuisse’s NTN Innovation Booster programme Imagine and develop the healthcare of tomorrow Innovation to tackle healthcare challenges Innovation in healthcare is key to tackle the challenges faced by the healthcare system in a deeply changing societal landscape.It becomes increasingly recognized that innovation must be centred around the patient…
Read MoreQualimatest & SAPHIR join forces to become qmt
qmt | The industry’s quality test and control reference On 9 January 2020, SAPHIR and Qualimatest announced that their organisations were merging under a new identity: qmt. After 30 years of developing a large panel of quality test and control solutions and products for industrial partners; the French and Swiss companies have decided…
Read MoreOxipit partners with HealthCare Konnect | Press Release
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria. The partnership aims to introduce vanguard AI diagnostic capabilities and improve detection of 75 pathologies, including tuberculosis, to one of the largest markets in Africa.
Read MoreIDT partners with SOPHiA GENETICS | Press Release
Leading genomics solutions, combined with advanced analytics, provide benefits to hospitals and patients
Read More